TSC2 and neoplasm: On the other hand, TSC2-deficient tumors with impaired eIF2αP displayed accelerated initiation by ~23 days compared to TSC2-deficient control tumors whereas the rates of tumor growth did not significantly differ between the two cell types (Fig. 6b; compare graphs e and h) (e and g).